Patient access to gene therapies for cancer likely to increase in the next decade: GlobalData Read more
Key unmet needs in HNSCC may be partly addressed by clinical development in next decade: GlobalData Read more
CRISPR-based cancer therapies likely to be a disruptive technology in healthcare: GlobalData Read more